Literature DB >> 34448397

Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites.

Parbeen Singh1,2, Brian Youden3,4, Yikun Yang5, Yongli Chen1,2, Andrew Carrier3, Shufen Cui2, Ken Oakes6, Mark Servos4, Runqing Jiang7, Xu Zhang3.   

Abstract

Multimodal nanotherapeutic cancer treatments are widely studied but are often limited by their costly and complex syntheses that are not easily scaled up. Herein, a simple formulation of glucose-oxidase-coated CuS nanoparticles was demonstrated to be highly effective for melanoma treatment, acting through a synergistic combination of glucose starvation, photothermal therapy, and synergistic advanced chemodynamic therapy enabled by near-infrared irradiation coupled with Fenton-like reactions that were enhanced by endogenous chloride.

Entities:  

Keywords:  Fenton reaction; cancer therapy; copper sulfide nanoparticles; glucose oxidase; starvation therapy

Mesh:

Substances:

Year:  2021        PMID: 34448397     DOI: 10.1021/acsami.1c12235

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.

Authors:  Jinsong Liu; Yueyao Lu; Yuyang Dai; Ying Shen; Cheng Zeng; Xiuling Liu; Huayi Yu; Jianzhong Deng; Wenbin Lu
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.